Carna Biosciences Inc
TSE:4572
Carna Biosciences Inc
Operating Income
Carna Biosciences Inc
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Carna Biosciences Inc
TSE:4572
|
Operating Income
-¥1.1B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-14%
|
|
CMIC Holdings Co Ltd
TSE:2309
|
Operating Income
¥5.5B
|
CAGR 3-Years
30%
|
CAGR 5-Years
5%
|
CAGR 10-Years
4%
|
|
Medinet Co Ltd
TSE:2370
|
Operating Income
-¥1.4B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-4%
|
|
CellSource Co Ltd
TSE:4880
|
Operating Income
¥1.2B
|
CAGR 3-Years
43%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
Linical Co Ltd
TSE:2183
|
Operating Income
¥1.2B
|
CAGR 3-Years
50%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
4%
|
|
WDB coco Co Ltd
TSE:7079
|
Operating Income
¥1.1B
|
CAGR 3-Years
32%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
See Also
What is Carna Biosciences Inc's Operating Income?
Operating Income
-1.1B
JPY
Based on the financial report for Dec 31, 2023, Carna Biosciences Inc's Operating Income amounts to -1.1B JPY.
What is Carna Biosciences Inc's Operating Income growth rate?
Operating Income CAGR 10Y
-14%
Over the last year, the Operating Income growth was 12%. The average annual Operating Income growth rates for Carna Biosciences Inc have been -2% over the past three years , and -14% over the past ten years .